High-Volume versus Low-Volume for Esophageal Resections for Cancer: The Essential Role of Case-Mix Adjustments based on Clinical Data
Michel W.J.M. Wouters(The Netherlands Cancer Institute), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), H. E. Karim-Kos(Netherlands Comprehensive Cancer Organisation), Willem-Hans Steup, Harriet G. T. Blaauwgeers(Netherlands Comprehensive Cancer Organisation), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), H.W. Tilanus(Erasmus MC), Laurents P. S. Stassen(University Medical Center)
Cited by 140
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795